Joint call for national action on asthmaAugust 23, 1999Text of the letter from Professor George Alberti, President of the Royal College of Physicians, and Dr Martyn Partridge, Medical Adviser to the National Asthma Campaign: Dear Ms Jowell We are writing to draw your attention to the fact that this week the Royal College of Physicians, supported by the National Asthma Campaign, will launch newly developed asthma outcome measures that fit within the NHS Performance Assessment Framework (copy enclosed). We would like to take this opportunity to highlight our concern that these independently developed outcome measures, along with the British Guidelines on Asthma Management, will only ever have a partial impact on the lives of the UK's 3.4 million people with asthma unless they are backed up by Government establishing minimum standards for asthma. The efforts of individual organisations to improve asthma care will only truly benefit all people with asthma if they are supported by a national programme for asthma and national asthma guidelines, endorsed by the National Institute for Clinical Excellence. Early indications from research the National Asthma Campaign has conducted among health authorities shows that asthma is not a local priority for many primary care groups in England. Of the 70 health authorities who responded to a National Asthma Campaign survey, only 18 stated that they would be including asthma in their health improvement programmes. With such a common condition causing so much morbidity and costing the NHS £672 million a year, we believe this has to be acted upon soon. We would welcome the opportunity to meet with you and your officials to discuss how the Royal College of Physicians and National Asthma Campaign could work with the Department of Health to build on existing work to ensure a National Service Framework or an equivalent programme for asthma is developed as early as possible. We look forward to hearing from you and can be contacted at the National Asthma Campaign on 0171 226 2260 ext 353 or at the Royal College of Physicians on 0171 935 1174 ext.254. Royal College of Physicians |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Exposures to metals and diesel emissions in air linked to respiratory symptoms in children Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||